Chapter 1: The nomenclature and definition of nonalcoholic fatty liver disease -- Chapter 2: Nonalcoholic fatty liver disease versus metabolic associated fatty liver disease -- Chapter 3: Natural history of nonalcoholic fatty liver disease -- Chapter 4: Hepatocellular carcinoma in nonalcoholic fatty liver disease -- Chapter 5: Genetics and epigenetics in nonalcoholic fatty liver disease -- Chapter 6: The place of transabdominal liver biopsy in nonalcoholic fatty liver disease -- Chapter 7: Alternative methods for liver biopsy - endoscopic ultrasound-guided and transjugular liver biopsy- endoscopic ultrasound-guided and transjugular liver biopsy -- Chapter 8: Morphopathology of nonalcoholic fatty liver disease -- Chapter 9: 2D shear wave elastography performance in the diagnosis of nonalcoholic fatty liver disease -- Chapter 10: Vibration controlled transient elastography and controlled attenuation parameter for staging nonalcoholic fatty liver disease -- Chapter 11: The value of serologic markers/scores in the assessment of nonalcoholic fatty liver disease -- Chapter 12: Nonalcoholic fatty liver disease within other causes of chronic liver diseases.-Chapter 13: Pathophisiology and risk stratification in cardiovascular diseases and NAFLD -- Chapter 14: Type 2 diabetes mellitus and insulin resistance in nonalcoholic fatty liver disease -- Chapter 15: Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease -- Chapter 16: Endocrinopathies in nonalcoholic fatty liver disease -- Chapter 17: Nonalcoholic Fatty liver disease and extraheoatic malignancies -- Chapter 18: Psychological burden of NAFLD and psychiatric disorders as extrahepatic manifestations -- Chapter 19: Obstructive sleep apnea syndrome and nonalcoholic fatty liver disease -- Chapter 20: Nonalcoholic fatty liver disease and psoriasis -- Chapter 21: Current management and pipeline treatment approaches in NAFLD - summary of ongoing RCTs and future directions -- Chapter 22: Practical clinical cases in nonalcoholic fatty liver disease. .